CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris [Phase 2]
Summary
Phase 2 trial of VAY736 in Pemphigus Vulgaris has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Pemphigus Vulgaris | Phase 2 | Status: TERMINATED | Results posted: 2020-10-19